Trial · NCT07912502
Feasibility of a Mindfulness and Physical Activity Promotion Intervention After Anterior Cruciate Ligament Reconstruction
NCT07912502, Not applicable, Not yet recruiting, University of Virginia
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Feasibility of a Mindfulness and Physical Activity Promotion Intervention After Anterior Cruciate Ligament Reconstruction. Trials, record NCT07912502. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912502
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Feasibility of a Mindfulness and Physical Activity Promotion Intervention After Anterior Cruciate Ligament Reconstruction
- NCT number
- NCT07912502
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 24 participants, estimated
- Lead sponsor
- University of Virginia
- Conditions
- Anterior Cruciate Ligament (ACL) Reconstruction
- Interventions
- Mind in Motion
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment Rate | Through completion of enrollment | Proportion of prescreened, eligible individuals who consent and enroll in the study, calculated as the number of participants who sign informed consent/assent divided by the number who pass prescreening. |
| Primary | Retention Rate | Baseline (Week 1) through Week 11 | Proportion of enrolled participants who complete the study through the Week 11 retention assessment. A pre-specified go/no-go benchmark of ≥85% retention was established. |
| Primary | Mindfulness Session Completion | Weeks 2 through 7 (6-week intervention period) | Percentage of prescribed Headspace mindfulness sessions (5 per week for 6 weeks; 30 total) completed per participant, captured via the Headspace API. A pre-specified go/no-go benchmark of ≥80% |
| Primary | Oura Ring Wear Adherence | Weeks 2 through 7 (6-week intervention period) | Percentage of intervention days with valid Oura Ring wear per participant. A pre-specified go/no-go benchmark of ≥80% of days was established. |
| Primary | Acceptability of Intervention Measure (AIM) Score | Week 7 (post-intervention) | Participant-rated acceptability of the Mind in Motion intervention, assessed using the 4-item Acceptability of Intervention Measure (scored 1-5; higher scores indicate greater acceptability). A pre-specified go/no-go benchmark of mean AIM ≥4.0 was established. |
| Secondary | Change in Injury-Related Fear (Tampa Scale of Kinesiophobia-11, TSK-11) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in TSK-11 total and subscale scores (range 11-44; higher scores indicate greater fear of movement/reinjury). A pre-specified go/no-go benchmark of ≥4-point change (published minimal detectable change) was established. |
| Secondary | Change in Psychological Readiness for Return to Activity (ACL-Return to Sport after Injury scale, ACL-RSI) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in ACL-RSI score (0-100 scale; higher scores indicate greater psychological readiness). |
| Secondary | Change in Reinjury Anxiety (Reinjury Anxiety Inventory, RIAI) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in RIAI score, assessing anxiety specifically related to reinjury. Scores range from 0 to 45 and higher scores reflect higher, more severe levels of re-injury anxiety. |
| Secondary | Change in Athletic Identity (Athletic Identity Measurement Scale, AIMS) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in AIMS score, assessing strength of identification with the athlete role. Scores range from 7 to 49 and higher scores indicate a stronger and more exclusive self-identification as an athlete. |
| Secondary | Change in Objectively Measured Moderate-to-Vigorous Physical Activity (MVPA) | Pre-intervention 7-day wear period (Week 1) compared to post-intervention 7-day wear period (Week 7) | Within-person change in daily MVPA (minutes/day) measured via a thigh-worn activPAL accelerometer over a 7-day wear period before and after the intervention. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Go/No-Go Task | Primary outcome |
Source ConductCognition
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912502
GET https://conductscience.org/api/trials/v1/NCT07912502/registered